OptiNose (OPTN) Short Interest Ratio & Short Volume → get a piece of the profit from this land (From True Market Insiders) (Ad) Free OPTN Stock Alerts $1.26 -0.03 (-2.33%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability OptiNose Short Interest DataCurrent Short Volume5,920,000 sharesPrevious Short Volume3,210,000 sharesChange Vs. Previous Month+84.42%Dollar Volume Sold Short$4.86 millionShort Interest Ratio / Days to Cover5.2Last Record DateApril 30, 2024Outstanding Shares113,040,000 sharesPercentage of Shares Shorted5.24%Today's Trading Volume899,366 sharesAverage Trading Volume2,202,153 sharesToday's Volume Vs. Average41% Short Selling OptiNose ? Sign up to receive the latest short interest report for OptiNose and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOPTN Short Interest Over TimeOPTN Days to Cover Over TimeOPTN Percentage of Float Shorted Over Time Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. OptiNose Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20245,920,000 shares $4.86 million +84.4%N/A5.2 $0.82 4/15/20243,210,000 shares $3.82 million +3.2%N/A5.3 $1.19 3/31/20243,110,000 shares $4.54 million -2.8%N/A5.7 $1.46 3/15/20243,200,000 shares $5.98 million -0.3%N/A5.9 $1.87 2/29/20243,210,000 shares $5.71 million -10.8%N/A8.5 $1.78 2/15/20243,600,000 shares $4.86 million +5.9%N/A10.1 $1.35 Get the Latest News and Ratings for OPTN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,400,000 shares $4.28 million -2.9%N/A10.8 $1.26 1/15/20243,500,000 shares $4.45 million -4.6%N/A11.4 $1.27 12/31/20233,670,000 shares $4.73 million -1.1%N/A11.5 $1.29 12/15/20233,710,000 shares $4.30 million +1.1%N/A11.9 $1.16 11/30/20233,670,000 shares $4.59 million -1.9%N/A11.6 $1.25 11/15/20233,740,000 shares $4.64 million -1.8%N/A14 $1.24 10/31/20233,810,000 shares $4.31 million +1.1%N/A12.6 $1.13 10/15/20233,770,000 shares $4.67 million -2.3%N/A12 $1.24 9/30/20233,860,000 shares $4.75 million -15.2%N/A10.8 $1.23 9/15/20234,550,000 shares $6.23 million +23.3%N/A11.4 $1.37 8/31/20233,690,000 shares $4.39 million -3.2%N/A6.3 $1.19 8/15/20233,810,000 shares $4.72 million No ChangeN/A5.7 $1.24 7/31/20233,810,000 shares $4.59 million -16.6%N/A5.6 $1.21 7/15/20234,570,000 shares $4.34 million +24.9%N/A7.1 $0.95 6/30/20233,660,000 shares $4.50 million +53.8%N/A6.3 $1.23 6/15/20232,380,000 shares $2.69 million -0.4%N/A4.5 $1.13 5/31/20232,390,000 shares $2.99 million -0.8%N/A7.8 $1.25 5/15/20232,410,000 shares $4.70 million -1.2%N/A10.3 $1.95 4/30/20232,440,000 shares $4.17 million -3.6%N/A16.2 $1.71 4/15/20232,530,000 shares $4.81 million -2.3%N/A16 $1.90 3/31/20232,590,000 shares $5.00 million +4.9%N/A16.6 $1.93 3/15/20232,470,000 shares $4.47 million -2.8%N/A16.3 $1.81 2/28/20232,540,000 shares $4.57 million +0.8%4.9%12.9 $1.80 2/15/20232,520,000 shares $4.33 million -4.2%4.9%12.2 $1.72 1/31/20232,630,000 shares $4.71 million -4.7%N/A11.4 $1.79 1/15/20232,760,000 shares $4.97 million +6.2%N/A13.2 $1.80 12/30/20222,600,000 shares $4.81 million -5.8%N/A12.5 $1.85 12/15/20222,760,000 shares $4.83 million +16.0%N/A13.4 $1.75 11/30/20222,380,000 shares $4.21 million -4.8%N/A11.9 $1.77 11/15/20222,500,000 shares $4.63 million -5.7%N/A17.1 $1.85 10/31/20222,650,000 shares $9.25 million +1.9%5.3%23.2 $3.49 10/15/20222,600,000 shares $8.63 million +2.0%5.2%19.8 $3.32 9/30/20222,550,000 shares $9.33 million +23.2%5.1%19.2 $3.66 9/15/20222,070,000 shares $7.35 million -0.5%4.1%13.5 $3.55Millionaire Investor makes surprising election prediction (Ad)Millionaire Investor Makes Surprising Election Prediction Louis Navellier says he knows who's going to win the election. And how they could send six specific AI stocks through the roof on their first day.Click here for the full story… OPTN Short Interest - Frequently Asked Questions What is OptiNose's current short interest? Short interest is the volume of OptiNose shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 5,920,000 shares of OPTN short. Learn More on OptiNose's current short interest. What is a good short interest ratio for OptiNose? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OPTN shares currently have a short interest ratio of 5.0. Learn More on OptiNose's short interest ratio. Is OptiNose's short interest increasing or decreasing? OptiNose saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 5,920,000 shares, an increase of 84.4% from the previous total of 3,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does OptiNose's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to OptiNose: Context Therapeutics Inc. (0.05%), Amylyx Pharmaceuticals, Inc. (18.07%), Karyopharm Therapeutics Inc. (14.59%), PDS Biotechnology Co. (18.70%), Nuvectis Pharma, Inc. (13.15%), Cartesian Therapeutics, Inc. (6.12%), Vistagen Therapeutics, Inc. (4.86%), DiaMedica Therapeutics Inc. (0.48%), Coya Therapeutics, Inc. (1.41%), Seres Therapeutics, Inc. (14.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short OptiNose stock? Short selling OPTN is an investing strategy that aims to generate trading profit from OptiNose as its price is falling. OPTN shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against OptiNose? A short squeeze for OptiNose occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OPTN, which in turn drives the price of the stock up even further. How often is OptiNose's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPTN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Context Therapeutics Short Interest Amylyx Pharmaceuticals Short Interest Karyopharm Therapeutics Short Interest PDS Biotechnology Short Interest Nuvectis Pharma Short Interest Cartesian Therapeutics Short Interest Vistagen Therapeutics Short Interest DiaMedica Therapeutics Short Interest Coya Therapeutics Short Interest Seres Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OPTN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsProtect Your Bank Account Before It’s Too LateWeiss RatingsUrgent Nvidia WarningAltimetry